pulmonary%20arterial%20hypertension
PULMONARY ARTERIAL HYPERTENSION
Pulmonary arterial hypertension is a syndrome resulting from restricted flow through the pulmonary arterial circulation resulting in increased pulmonary vascular resistance and ultimately leading to right heart failure.
It is a part of the spectrum of pulmonary hypertension, which is hemodynamic and pathophysiological condition defined as an increase in mean pulmonary arterial pressure ≥25 mmHg at rest.
Typical symptoms include progressive dyspnea on exertion, palpitations, fatigue, weakness, angina, syncope and abdominal distention.

Patient Education

Genetic Testing/Counseling

  • Should be offered to relatives of patients with familial pulmonary arterial hypertension (PAH), if available
  • Idiopathic pulmonary arterial hypertension (IPAH) patients should be advised regarding the availability of genetic testing & counseling for their relatives

Physical Activity

  • Physical activity to maintain adequate skeletal muscle conditioning should be limited to a symptom-free level
  • Low-level aerobic exercise (eg walking) as tolerated, is recommended
  • Heavy physical exertion or isometric exercise, exercise after meals or in extreme temp should be avoided

Travel/Altitude

  • Exposure to high altitudes may contribute to hypoxic pulmonary vasoconstriction & may not be well tolerated
  • Avoid mild degrees of hypobaric hypoxia that starts at altitude between 1500-2000 meters
  • Supplemental O2 is needed in commercial airplanes when pre-flight pulse oximetry saturation is <92%

Pregnancy

  • Pregnancy, labor, delivery & postpartum period are potentially devastating with 30-50% mortality in patients with PAH
    • Appropriate method of birth control may be used by women of childbearing potential
    • Barrier contraceptive methods & progesterone-only preparations are safe for PAH patients 
  • Pregnancy should be avoided or terminated in women with cyanotic congenital heart disease, PH & Eisenmenger syndrome
  • During menopause, hormonal therapy may be considered for intolerable menopausal symptoms in conjunction with oral anticoagulation

Psychosocial Support

  • If needed, refer patient to psychiatrist/psychologist to assist in dealing with anxiety &/or depression about their disease state
  • If available, patients & families should be referred to support groups as these are useful in improving the understanding & acceptance of the disease condition
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 25 Oct 2016

Nivolumab did not meet the primary endpoint of superior progression-free survival (PFS) vs platinum-based chemotherapy in the phase III Checkmate026 trial in patients with stage IV recurrent, PD-L1–positive non-small-cell lung carcinoma (NSCLC), according to results reported recently at the European Society of Medical Oncology (ESMO) Congress 2016. 

Pearl Toh, 24 Nov 2016
New treatments such as pirfenidone and nintedanib slow lung function decline and progression of idiopathic pulmonary fibrosis (IPF), although response to treatment can vary dramatically among patients, according to a presentation at the 21st Congress of the Asian Pacific Society of Respirology (APSR 2016) held in Bangkok, Thailand.
16 Oct 2016
Irritable bowel syndrome and asthma share a bidirectional association, a new study reports. Further, atopy potentially plays a role in the underlying mechanisms of this association.
Audrey Abella, 09 May 2018
The potent and highly selective RET* inhibitor BLU-667 was well-tolerated and exhibited promising clinical activity among patients with advanced, RET-altered solid cancers that progressed despite multikinase inhibitor therapy, according to data presented at AACR 2018.